Abstract
The long-term treatment of human immunodeficiency virus (HIV)-infected children with combination antiretroviral therapy (cART) requires assessment of potential adverse effects, such as osteoporosis. Longitudinal data on bone mineral density (BMD) in HIV-infected children showed that cumulative treatment with cART had a positive impact on BMD over time. © 2012 The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Author supplied keywords
Cite
CITATION STYLE
Bunders, M. J., Frinking, O., Scherpbier, H. J., Van Arnhem, L. A., Van Eck-Smit, B. L., Kuijpers, T. W., … Pajkrt, D. (2013). Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy. Clinical Infectious Diseases, 56(4), 583–586. https://doi.org/10.1093/cid/cis917
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
